Skip to main content
| News

The DayOne Accelerator, in its 3rd year, is now accepting applications

02.10.2020

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

If you are a digital health entrepreneur that wants to gain feedback on your innovation, build connections across the healthcare ecosystem and potentially win a place in the DayOne Accelerator, then you are in the right place.  The accelerator will again help you to develop your digital health venture together with one of Europe’s leading ecosystems with coaching, space and potential funding. The first step to send in your application before the 23.10.20 deadline. We will let you know by 05.11.2020 whether you are shortlisted for the accelerator program and therefore invited to in the DayOne Open Innovation Session

This year the accelerator will have three categories: Patient Centric Innovation, Diabetes & Metabolism, and Value Based Healthcare. For more information about the categories, full list of winner benefits, list of previous winners and more, visit the DayOne Accelerator page.

Don’t forget to apply before the 23.10.20 deadline, and feel free to send those in your network who could also be interested in participating;  after all, we do love collaboration at DayOne.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.